SEC-sourced researchBeta
INDV
Indivior Pharmaceuticals, Inc.
Company comparison ↗
Data passport
- CIK
- 0001625297
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 6, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 1,093,000,000.0000 | Feb 26, 2026 |
| December 2024 | 1,188,000,000.0000 | Feb 26, 2026 |
| December 2025 | 1,239,000,000.0000 | Feb 26, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,239,000,000.0000 | 210,000,000.0000 | -27,000,000.0000 | 1,201,000,000.0000 | 1,300,000,000.0000 | Feb 26, 2026 |
| December 2024 | 1,188,000,000.0000 | 7,000,000.0000 | 36,000,000.0000 | 1,316,000,000.0000 | 1,652,000,000.0000 | Feb 26, 2026 |
| December 2023 | 1,093,000,000.0000 | -126,000,000.0000 | -300,000,000.0000 | 1,758,000,000.0000 | 1,942,000,000.0000 | Feb 26, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.24B | December 2025 | Feb 26, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.19B | December 2024 | Feb 26, 2026 | 10-K |
| Net incomeNetIncomeLoss | $210M | December 2025 | Feb 26, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$27M | December 2025 | Feb 26, 2026 | 10-K |
| Total assetsAssets | $1.2B | December 2025 | Feb 26, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.3B | December 2025 | Feb 26, 2026 | 10-K |
New filings
- 425INDV · Indivior Pharmaceuticals, Inc.Oct 6, 2026 · Other
- 8-KINDV · Indivior Pharmaceuticals, Inc.Oct 6, 2026 · Current event
- SCHEDULE 13GINDV · Indivior Pharmaceuticals, Inc.Sep 30, 2026 · Other
- 425INDV · Indivior Pharmaceuticals, Inc.Sep 17, 2026 · Other
- 8-KINDV · Indivior Pharmaceuticals, Inc.Sep 17, 2026 · Current event
- 8-KINDV · Indivior Pharmaceuticals, Inc.Sep 15, 2026 · Current event
- EFFECTINDV · Indivior Pharmaceuticals, Inc.Sep 11, 2026 · Other
- 424B3INDV · Indivior Pharmaceuticals, Inc.Sep 11, 2026 · Other
- S-4/AINDV · Indivior Pharmaceuticals, Inc.Sep 9, 2026 · Other
- S-4INDV · Indivior Pharmaceuticals, Inc.Aug 28, 2026 · Other
- 4INDV · Indivior Pharmaceuticals, Inc.Aug 27, 2026 · Other
- 10-KINDV · INDIVIOR PHARMACEUTICALS, INC.Feb 26, 2026 · Annual